Agonistas LH-RH como alternativa terapéutica en pacientes con hiperplasia benigna de próstata (HBP) y contraindicación quirúrgica. Seguimiento a largo plazo

Archivos Espanoles de Urologia

Volumn 49, Issue 9, 1996, Pages 923-927

  Granados Loarca, Edgar Antonio ^a,b   Chéchile Toniolo, Gilberto ^a   Villavicencio Mavrich, Humberto ^a  

^a FUNDACIÓ PUIGVERT   (Spain)

^b NONE   (Guatemala)

Author keywords

Benign hypertrophy; LH RH analogues; Medical treatment; Prostate

Indexed keywords

GONADORELIN AGONIST; GOSERELIN; TESTOSTERONE;

ARTICLE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOMATOLOGY; URINE RETENTION;

FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; MALE; PROSTATIC HYPERPLASIA; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; URINARY BLADDER NECK OBSTRUCTION;

EID: 0029903658     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. AHMAN, F. R.; CITRIN, D. L.; DE HAAN H. A. y cols.: "Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer." J. Clin. Oncology., 5: 912, 1987.
2. BEACOCK, A. J.; BUCK, A. C.; PEELING, W. B. y cols.: "The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI." Br. J. Urol., 59: 436, 1987.
3. GRAYHAACK, J. T.; KEELER, T. C.; KOZLOWSKI, J. M.: "Carcinoma of the prostate." Cancer., 60: 589, 1987.
4. VARENHORST, E.; ALUND, G.: "Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment." Urology, 25: 354, 1985.
5. HEDLUND, H.; ANDERSSON, K. E.; EK, A.: "Effects of prazosin in patients with benign prostatic obstruction." J. Urol., 130: 275, 1983.
6. KANE, M. M.; FIELDS, D. W.; VAUGHAN, E. D.: "Medical management of benign prostatic hyperplasia." Urology, (Suppl.) 36: 5, 1990.
7. LEPOR, H.: "Role of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia." Urol. Clin. North Am., 17: 651, 1990.
8. MC CONNELL, J. D.: "Androgen ablation and blockers in the treatment of benign prostatic hyperplasia." Urol. Clin. North Am., 17: 661, 1990.
9. WALZ, D. H.; WENDEROTH, U.; JACOBI, G. H.: "Suprapubic transvesical sonography of the prostate: determination of prostate size." Eur. Urol., 9: 148, 1983.
10. "HALLEMANS, E.; DECLERCQ, G.; DENIS, L.: "Transrectal ultrasonotomography." Eur. Urol., 3: 37, 1977.
11. HUGGINS, C.; STEVENS, R. A.; "The effect of castration on benign hypertrephy of the prostate in man." J. Urol., 43: 705, 1940.
12. WENDEL, E. F.; GRANNEN, G. E.; PUTONG, R B. y cols.: "The effect of orchiectomy and estrogens on benign prostatic hyperplasia." J. Urol., 108: 116, 1972.
13. SCHOEDER, F. H.; WESTERHOF, M.; BOSCH, R. y cols.: "Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserilin: a report on 6 cases. Eur. Urol., 12: 318, 1986.
14. EKMAN, P.: "Nonsurgical treatment of benign prostatic hypertrophy." World J. Urol., 6: 209, 1989.
15. STONE, N.N.: "Flutamide in treatment of benign prostatic hypertrophy." Urol., (Suppl.) 34: 64, 1989.
16. STONER, E.: "El desarrollo clínico del inhibidor de la 5α-reductasa, finesterida." J. Steroid Biochem Molec. Biol. 37: 375, 1990.
17. GRANADOS, E.: "Finasteride una alternative a la cirugía de la hiperplasia prostática benigna (HPB)." Act. Urol. Esp., en prensa.
18. LINDNER, A; RAMÓN, J.; BROOKES, M. E.: "Controlled study of cimetidine in the treatment of benign prostatic hypertrophy." Br. J. Urol., 66: 55, 1990.
19. PETERS, C. A.; WALSH, R L.: "The effect of nafarelin acetate aa luteinizing-hormone-releasing hormone agonist on benign prostatic hyperplasia." N. Engl. J. Med., 317: 599, 1987.
20. KEANE, P. E; TIMONEY, A. G.; KIELY, E. y cols,: "Response of the benign hypertrophied prostate to treatment with an LHRH analogue." Br. J. Urol., 62: 163, 1988.
21. LUKKARINEN, O.: "Effect of LH-RH analogue in patients with benign prostatic hyperplasia." Urology., 37: 92, 1991.
22. BROWMAN, S. A.; YONG, R.: "The use of an LH-RH agonist in patients with urinary retention." C-568, 22nd. Congress Societe International d'Urologie. Sevilla, 1991.
23. CHÉCHILE, G.; MALLO, N. VALUES, L.: "Eficacia de un análogo de 6n-RH (HOE766) en el tratamiento de pacientes de alto riesgo con hiperplasia benigna de prostata y sonda vesical a permanencia." Urol. Panam, 3: 16, 1991.